Bharat Biotech welcomes budget allocation of Rs 35000 crore for Covid vaccine

Published On 2021-02-02 07:06 GMT | Update On 2021-02-02 07:06 GMT

Hyderabad: Covaxin maker Bharat Biotech on Monday described as "far reaching" initiative the allocation of Rs 35,000 crore for Covid-19 vaccination in the Union Budget and said it would help the country become free of the viral disease.

Dr. Reddys Laboratories Ltd said the budget was growth- oriented with a lot of positive interventions and with "something in it for everyone".

Welcoming the proposal for Rs 35,000 crore outlay for Covid-19 vaccines, city-based Bharat Biotech Chairman and Managing Director Krishna Ella said "Its a great step ahead, and far-reaching budget announcement., providing Rs 35,000 crore for Covid-19 vaccination in 2021-22."

The Finance Minister's commitment providing more funds in order to contain the coronavirus pandemic and provide an effective, smooth path for the vaccination scheme "will help contain, and lead our nation towards accomplishing a Covid-19 disease free Bharat," he said in statement here.

The indigenous Covid-19 vaccine Covaxin and Oxford's Covishield are being produced in the country and used during the ongoing inoculation drive.

The Rs 64,180 crore spending plan for healthcare over the next six years to be spent on primary, secondary and tertiary healthcare, in addition to the National Health Mission was also a welcome move, he said.

This would strengthen public health services as 17,000 rural and 11,000 urban health and wellness centres and integrated public health labs would be set up in each district, Ella said.

The government focus, on three areas - preventive health, curative health and well-being, was also very reassuring, he said.

"With this landmark budget, the Government of India has signalled its intention to make health a cornerstone of the future success of our country. The allocation to vaccines signals a shift to preventive health care, a validation of the fact that vaccines are the most cost effective health care interventions, he added.

Chairman of Dr Reddy's K Satish Reddy said the government has taken a big step on healthcare, making an outlay of 2.23 lakh crores, a 137 per cent increase from last year, a step that was "long overdue". "On innovation and R&D (Research and Development), the additional allocation of Rs 50,000 crore over five years through the National Research Foundation marks a good beginning in improving the research eco-system in the country, he opined.

As with all budgets, this too contained concrete proposals that were encouraging but it was the execution that finally matters, he said, expressing hope this time the government gets it right.

Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Bharat Biotech welcomes budget allocation of Rs 35000 crore for Covid vaccine

Similar News

PCI President Montu Patel granted pre-arrest bail in corruption case

Alembic Pharma gets USFDA nod for anticonvulsant drug Carbamazepine Extended Release

Licences of 2 pharma stores suspended for unethical trade practices

16912 Jan Aushadhi Kendras opened till June 30: Minister

Mankind Pharma incorporates wholly owned subsidiary in Sri Lanka

Sun Pharma Agrees To Rs 1,654 Cr Settlement In U.S. Pricing Row

No Special Price for Novel Pack: NPPA Panel Turns Down Sun Pharma's Amoxicillin-Clavulanic Formulation

CDSCO Panel Seeks Safety Data on 5% Lenalidomide TDS Before Clearing 8% Patch Trial